NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases
- Conditions
- Myelodysplastic SyndromeAcute Myeloid Leukemia
- Interventions
- Drug: Preparative RegimenBiological: NK CellsBiological: CD34 Graft/Anti-thymocyte globulinBiological: Donor TCR α/β-depleted Graft/ATG
- First Posted Date
- 2011-06-09
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 25
- Registration Number
- NCT01370213
- Locations
- 🇺🇸
University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸Emory University, Atlanta, Georgia, United States
Preservation of Ovarian Function After Hematopoietic Cell Transplant
- Conditions
- Myeloproliferative DisordersNon-Hodgkin LymphomaAcute Myeloid LeukemiaMultiple MyelomaHodgkin Disease
- Interventions
- Biological: reduced intensity allogeneic HCTBiological: hematopoietic cell transplant
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2017-12-05
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 19
- Registration Number
- NCT01343368
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 2
- Registration Number
- NCT01312818
- Locations
- 🇺🇸
Masonic Cancer Center, University if Minnesota, Minneapolis, Minnesota, United States
Selecting a Favorable KIR Donor in Unrelated HCT for AML
- Conditions
- Acute Myelogenous Leukemia
- Interventions
- Other: KIR genotype
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 506
- Registration Number
- NCT01288222
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States
Influenza Vaccine Post Allogeneic Transplant
- Conditions
- Hematologic MalignancyHematopoietic Stem Cell Transplant
- Interventions
- Biological: Influenza vaccine
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 68
- Registration Number
- NCT01215981
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
AHN-12 Biodistribution in Advanced Leukemia
- Conditions
- Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeChronic Myelogenous Leukemia
- Interventions
- Biological: 90Y-AHN-12
- First Posted Date
- 2010-09-22
- Last Posted Date
- 2017-12-05
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT01207076
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
- Conditions
- Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
- Interventions
- Biological: Interleukin-2Biological: Natural killer cells
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 16
- Registration Number
- NCT01181258
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 11
- Registration Number
- NCT01173016
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
- Conditions
- Brain TumorGlioblastomaMedulloblastomaEpendymomaAnaplastic Astrocytoma
- Interventions
- Biological: Dendritic Cells
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT01171469
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
- Conditions
- Hematologic MalignancyAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia in Blast CrisisChronic Myeloproliferative DiseaseAnemia, Refractory, With Excess of BlastsSmall Lymphocytic LymphomaMarginal Zone B-cell LymphomaFollicular Lymphoma
- Interventions
- Biological: Treg cellsBiological: CD3+ Teff cellsRadiation: Total body irradiationBiological: Umbilical cord blood transplantation
- First Posted Date
- 2010-07-15
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Registration Number
- NCT01163201
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States